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ABSTRACT
Objectives: To examine current UK practice in diagnosis of patients under 65 with young onset demen-
tia, within 5 years of date of diagnosis, identified from electronic health records of 8 NHS mental health 
trusts. 
Methods: Patients diagnosed with young onset dementia were assembled from the UK-Clinical Record 
Interactive System, (UK-CRIS) using diagnosis of dementia as the index date. A pre-designed proforma, 
derived by international Delphi consensus from experts in the field in previous work, was used to 
assess components of the diagnostic assessment in 402 electronic health records across 8 NHS sites. 
Information was extracted on key aspects of clinical and physical examination according to both a 
minimum and gold standard.
Results:  Percentage compliance rates analysed by NHS site and statement, including compliance for 
site for minimum standard (11 statements), the additional 20 statements required for Gold standard, 
and the complete Gold standard set (31 statements) show that the additional 20 statements in the 
Gold standard had consistently higher compliance rates for every site compared to the minimum set.
Conclusion: Findings confirmed variation in clinical practice and identified commonly missed items 
in examination and enquiry compared to expert consensus. This suggests that a template proforma, 
which contains the key indicators for comprehensive assessment of dementia in young adults 
according to a quality standard could help support clinicians to improve record keeping and reduce 
gaps in knowledge.
Introduction
Young onset dementia (YOD) refers to dementia diagnosed 
in those aged 65 years and under. YOD is poorly recognised 
and often misdiagnosed (Konijnenberg et al., 2017; Salem et 
al., 2014) because presenting symptoms are complex, con-
ditions are heterogenous in presentation and atypical com-
pared to those of late onset disease (LOD). Alzheimer’s 
disease is common in YOD, accounting for a third of cases, 
but presentation is frequently atypical characterised by 
non-memory impairment, such as language, visuo-spatial, 
executive, behavioural or motor-led dysfunction (Graff-
Radford et al, 2021, O’Malley et al, 2019, Koedam et al 2010). 
Frontotemporal dementia is more frequent, characterised by 
behavioural changes, for example inappropriate social inter-
actions, lack of empathy, poor motivation, and reduced 
insight which can delay help-seeking (Kuruppu & Matthews 
2013, Draper et al, 2016). Alcohol-related dementia and HIV-
associated cognitive impairment require multidisciplinary 
and multi-agency approaches (Rao & Draper, 2018, 
Underwood & Winston, 2016).
Significant delays can arise in time to diagnosis from GP 
referral depending on service type (Hussey & Butler, 2019). 
Many younger people in the UK continue to be assessed and 
diagnosed in memory services where there is typically limited 
access to other multidisciplinary professionals (Rodda & Carter, 
2016). Clear evidence about the best practice approach to diag-
nosis is lacking. This raises concern as many dementia and 
memory clinics continue to employ routine procedures, screen-
ing measures and cognitive tests tailored to older patients that 
are often insufficient to identify the complexity of presentation 
in YOD and result in under-investigation with limited use of 
crucial supplementary investigations. Indeed, evidence sug-
gests that under-investigation is particularly common in 
non-specialist settings (Eriksson et al., 2014). Providing individ-
uals with an accurate diagnosis allows them and their families 
access to suitable treatments, support and research opportu-
nities. Timely diagnosis and improved recognition were rated 
by those with YOD as the highest priority for service improve-
ment, placing it above post-diagnostic support (Armari, 
Jarmolowicz, & Panegyres, 2013).
A UK-based study, called The Angela Project, has focused 
on developing guidance on best practice in diagnosis of 
dementia in younger adults. The Angela Project included an 
international Delphi study with secondary care clinical experts 
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(O’Malley, Parkes, Stamou, et al., 2020a) to establish the key 
indicators for comprehensive assessment of dementia in this 
patient group. The resulting consensus created two standards, 
a minimum standard and gold standard, which have provided 
a template for assessing the UK clinical practice in the current 
study. A knowledge exchange event was also conducted with 
the participating NHS Trust clinical leads to understand further 
common gaps in enquiry.
Our objectives were to identify differences in compliance 
with the minimum and gold standard a) at and between sites 
b) with dementia subtypes and c) to investigate possible expla-
nations for commonly missed items of enquiry and examination
Materials and methods
Study setting and data source
To undertake the audit, the platform UK-CRIS (UK-Clinical 
Record Interactive System) through the CRIS Network, was uti-
lised. The data for the study was extracted using the CRIS appli-
cation, which renders anonymised data from over two million 
electronic health records (EHR) for use for research and audit 
purposes (https://crisnetwork. co). The CRIS data have been 
extensively supplemented through natural language process-
ing applications using Generalised Architecture for Text 
Engineering software which apply information extraction tech-
niques allowing users to derive structured information from the 
text fields held in mental health records (Perera et al., 2016).This 
methodology was employed across the EHR from eight separate 
Trusts in England from both rural and urban locations.
Ethics The Angela Project was approved by the Health 
Research Authority in England and by the South Central 
Berkshire Research Ethics Committee (REC ref 17/SC/0296). At 
each UK-CRIS site, a governance process with the CRIS oversight 
committee took place, to review the project as a CRIS-specific 
project and to agree to participation.
Sample All patients aged 65 years or younger who had 
received a diagnosis of dementia were identified from eight 
NHS trusts between September 2018 and November 2019. The 
date of the first recorded diagnosis before the age of 65 served 
as the index date for the retrospective search for the quality 
indicators. Patient records were excluded if it was apparent that 
the person was diagnosed later than 5 years ago (before 2014), 
if an individual was diagnosed in another NHS Trust and had 
since moved, so diagnostic information was not present in the 
files and if diagnostic information was in an associated, attached 
letter that the research team were unable to access. Patient data 
were denoted by a unique and stable pseudonym, (BRC_ID), 
consisting of a randomly generated string of characters to 
exclude use of any personally identifiable information from the 
patient records. Each individual entry record also included a 
document BRC_ID. These IDs do not allow researchers to iden-
tify specific patients and cannot be linked to the patient’s NHS 
number or individual Trust ID.
Quality indicators
Information was extracted relating to thirty-one key indicators 
from text fields of CRIS EHR of 402 anonymised patients with a 
diagnosis of dementia under the age of 65. Demographic data 
including gender, age at diagnosis, dementia type and time 
since diagnosis were also collected. The thirty-one indicators, 
highlighting key components of the comprehensive assessment 
of dementia in young adults were derived from an international 
Delphi study with expert secondary care clinicians in the field 
of young onset dementia. The Delphi study resulted in two stan-
dards that experts deemed as critical and essential. The mini-
mum standards represent red flag indicators that were rated by 
all experts in the Delphi study as being absolutely essential or 
very important to diagnosis. The gold standard consists of a 
more comprehensive list of indicators that were rated as very 
important or absolutely essential by at least 80% of experts in 
the Delphi study.
Upon review, four statements from the original minimum 
and gold standards were deemed unascertainable from the free 
text case notes and others which had commonality were com-
bined into one statement as indicated in Appendix 2. Some 
exceptions were made to the original scoring schedule.
For some indicators an intermediate score of 0.5 was 
assigned as indicated below
• ACE-III – if the clinician used another screening tool, such 
as the Montreal Cognitive Assessment (MoCA) or Rowland 
Universal Dementia Assessment Scale (RUDAS) and provided 
appropriate reasons for using it, this was scored as 1.
• MRI as initial assessment – if there was a contra-indication to 
MRI e.g. metal implants/pacemaker obesity or claustropho-
bia, then this was scored as 0.5
For complete list of 31 indicators see table 5 in results section 
Data extraction
The key indicators were scored as present (1) or absent (0) in 
the text record according to a final template (Table 1).
Information about the quality indicators was extracted from 
the EHR, primarily from unstructured free text case notes. No 
access was available to correspondence or investigations 
reported elsewhere unless recorded in the clinical notes.
Data collection
Data collection took place directly through an on-site NHS 
device, and through the virtual desktop interface (VDI). The pilot 
phase of the audit took place between September 2018 and 
January 2019. During this pilot phase period the query and 
search terms were refined. Data collection from all eight sites 
took place between January 2019 and November 2019.
Stage 1
A Structured Query Language (SQL) script was inputted into 
the local SQL client of UK-CRIS to produce a list of anonymised 
identifier codes for the patient records that met our inclusion 
and exclusion criteria. The SQL output also provided demo-
graphic information from the anonymised patient records.
Stage 2
The web client of UK-CRIS interrogates the anonymised patient 
records using key text terms for each of the indicators which 
are automatically highlighted to aid identification (see Table 1 
for key terms). Only EHR records from patients referred to and 
diagnosed in memory or cognitive disorders clinics in mental 
health trusts were included in the audit, to ensure the findings 
reflected the usual Trust care pathway.
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Table 1. Minimum and gold Standards that have been transformed into indicators. Please see the table below for more details, key words, and scoring 
information:
Minimum Standard Statements
Statement 100% Official Statement Key words for search query types of Questions Scoring
Collateral history to ask an informant (e.g. wife/
husband) for a collateral history
inFORMAnt/corroborative/
Collateral hx
 /corroboration/third party/witness/wife 
concerned/husband concerned/seen with
Yes/no
 Has a clinician spoken to an informant 
for a collateral history?
0 or 1
Symptom type and 
mode of onset
to understand the symptom type 
and the mode of onset
Symptoms/mode of onset/symptom profile/
chronology/progression
Yes/no 





to ask for information about loss of 
sympathy/empathy towards 
others, disinhibited behaviour, 




 OR function for each of these?
Yes/no
 Has the clinician asked about loss of 
sympathy/empathy towards others, 
disinhibited behaviour, change in 
food preferences and changes in 
personality?
0 or 1
Physical health to enquire about changes in 
physical health
Yes/no
 Have there been any changes in physical 
health?
0 or 1
Full medical history to have a full medical history 
(including cardiovascular history)
Medical history/ Med Hx/cardiovascular risk/
CV risk/CVS
Yes/no
 Has a medical history been taken?
0 or 1
ADl if there have been any changes in 
activities of daily living
ADl/activities daily living/
 i.e. comments on ability to drive, make meals, 
pay bills, wash and dress etc
Yes/no
 Has there been a change in ADl?
0 or 1
Behaviour change to ask about changes in behaviour Behaviour change
 meaning e.g. verbal or physical aggressive, 
acting out of character
Yes/no




to ask if a first degree relative has 
had young onset dementia
FHx dementia/FHx YOD
 FHx eOD/POSitiVe Fhx 
 genetic testing/genetic mutation
Yes/ partially /no
 Has the clinician asked if the patient has 




Praxis neurological Assessment –
 Praxis
Praxis Yes/no
 Has Praxis been assessed?
0 or 1
Parkinsonism neurological Assessment –
 Parkinsonism
Parkinsonism OR ePSe Yes/no
 Have Parkinsonism OR ePSe been 
explored?
0 or 1




 Has the clinician established a rapport/





Statement Official Statement Possible Key word for search query Types of Questions Scoring
neurological 
symptoms
to assess neurological symptoms, 
including eye movements, 
Cerebellar signs




all neurological symptoms listed verbatim.
 motor symptoms/fasciculation/frontal signs 
or frontal release signs
 Could include weakness, gait, tremor, or 
absence of abnormal movements
Yes/no
 Have neurological symptoms been 
reported and noted?
0 or 1
Alcohol history to take an alcohol history Alcohol/etoh/etOH/ substance misuse Yes/no
 Has the clinician asked/explored the 
patient’s alcohol history?
0 or 1
Drug history to take a drug history Drugs/illicit drugs/ substance misuse Yes/no
 Has the clinician asked/explored the 
patient’s illicit drug history?
0 or 1
Risks to evaluate risks, for example 






 Has the clinician evaluated the patient’s 
risks, for example driving or in their 
place of work or home
0 or 1









 Ct/MRi/MtA atrophy/ protocol/ structural 
imaging
Yes/no
 Has baseline structural neuroimaging
 been done
0 or 1
Mood to exclude symptoms of mood 
disorder
Depression/low mood
 geriatric depression scale/gDS/
 mood inventory/dishevelled appearance/
anhedonia/affective disorder/ Formal 
mood inventory/mood screening
Yes/no
 Has the clinician mentioned symptoms 
of a mood disorder or indicated their 
absence?
0 or 1
Psychosis to exclude psychotic symptoms Psychosis/hallucinations/nPi/psychotic/ 
organic psychosis
 Perceptions, abnormal beliefs, delusions, VH 
– visual hallucinations
Yes/no
 Has the clinician asked about psychotic 
symptoms?
0 or 1
Medical conditions to consider previous medical 
conditions
Medical history
 if you can see that the patients’ other 
conditions have been noted in the 
assessment or it states that there are no 
other conditions.
Yes/no
 Have previous medical conditions been 
asked about or absence indicated (e.g. 
no significant medical history/hx)
0 or 1
(Continued)
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Stage 3
A scoring proforma containing the minimum and gold standard 
indicators was prepared. The authors (MOM, JC) manually read 
through the records and used the proforma to score whether 
each indicator was met. Records were read retrospectively from 
date of confirmed diagnosis to point of referral. Only informa-
tion available on the UK-CRIS platform was used when conduct-
ing the audit.
Statistical analysis
IBM SPSS v26 software was used in all statistical analyses. The 
threshold for null hypothesis significance testing was taken as 
p = 0.05.
Sample size. The sample size calculation was based on the 
requirement to estimate the compliance rate for each standard 
to within ±5% (95% confidence intervals). As there was no a 
priori information relating to the expected compliance esti-
mates, the most conservative value of 50% was taken. Observed 
compliance rates greater or smaller than 50% will have smaller 
confidence intervals.
Inter-rater reliability
Two raters independently extracted the data and scored the stan-
dards for the first 50 records examined. As the selected two raters 
constituted a fixed effect and they each rated all of the random 
selection of 50 records (random effect), a two-way, mixed effects 
Intraclass Correlation Coefficient (ICC(3,1) (Shrout & Fleiss, 1979) 
absolute agreement) was used to assess overall agreement. This 
showed good to excellent reliability for both the gold (ICC = 0.851 
(95%CI 0.751-0.912) and minimum (ICC = 0.858 (95% CI 0.763-
0.917) standards with the residuals evenly distributed above and 
below the line of equal scores. Agreement between the two raters 
for each of the 31 items was analysed using a weighted Kappa 
coefficient. The mean weighted Kappa scores for all 31 items was 
0.77 (sd = 0.15) and the lowest percentage agreement was 92%, 
indicating good consistency in the scoring between the two raters. 
The remaining records were therefore scored by one of the raters.
Tests of normality
Kolmogorov-Smirnov tests of normality indicated strong evi-
dence for non-normality for both compliance percentages for 
Past psychiatric 
symptoms
Ask about past psychiatric 
symptoms
Search psychiatric/psychiatrist/
 Past psychiatric hx/PPH
 Mental health
 they have noted that the patient has had 
depression or another psychiatric 
symptom/condition.
Yes/no
 Has the clinician asked about past 
psychiatric
 history/symptoms? 
 Abbreviations eg hx bipolar affective 




to conduct a physical examination Pe or physical examination
 this includes eCg, checking blood pressure, 
pulse or comments on chest/heart sounds 
etc
Yes/no
 Has the clinician conducted a physical 
examination?
0 or 1
Sleep to ask about sleep Sleep Yes/no




to obtain a three-generation history 




 ? use of symbols??
Yes/no
 Has a three-generation history of YOD 
been taken from the patient?
0 or 1
MRi is initial 
investigation
MRi should be the initial imaging 
investigation
MRi – to determine if first imaging done. if 
MRi was the first imaging done, rather 
than a Ct.
Yes/partially/no





ACe-iii the profile of results is important on 
the ACe-iii
ACe-iii or depending on circumstance – MoCA 
or RUDAS or other screening tool.
 if the clinician has used another screening 
tool, such as the MoCA or RUDAS and have 
provided their reasons for using it (see 
below for more info)
Yes/no
 Has the pattern/profile of the ACe-iii 
scores been discussed rather than just 
including the score itself?
0 or 1
MRi MRi dementia protocol 
incorporating t1, t2 and Flair 
images
term dementia protocol with MRi
 t1, t2 and Flair images
Yes/no
 Has the MRi protocol incorporating t1 
and Flair images been included?
0 or 1
Counselling the assessment should start with 
counselling to ascertain what 
patient and supporters require
Pre-diagnostic counselling
 Or diagnostic counselling
Did the assessment start with counselling 
to ascertain what the patient and 
supporters/carer understanding is of 
the procedure and what information 
they may receive e.g. a diagnosis?
0 or 1
History of lD establish if there is a known history 
of learning disability
lD/Downs syndrome/Down syndrome/
 learning disability/trisomy 21
 
Has the clinician established if there is a 




to include a mental state 
examination
MSe or mental state. 
 Usually starts with comments on appearance 
and behaviour,comments on speech and 
then mood, e.g. euthymic, dysthymic, 
thought content, and abnormal beliefs and 
perceptions
Has a mental state examination been 
conducted?
0 or 1
ACe-iii use for 
cognitive profile
An ACe-iii is useful to understand 
the cognitive profile
 Patterns of cognitive deficits 
provide clues to disease 
aetiology on the ACe-iii
ACe-iii or ACe-iii with pattern/profile/
domains/deficits
Has the ACe-iii been conducted?
 And is the breakdown of results on each 
section given e.g. language, memory, 
attention, visuospatial skills – usually 





Detailed neuropsychology testing 
should be considered if there is 
under performance on screening 
measures
neuropsychology +/- assessment/testing
 neuropsychology and ACe-3
 neuropsychology and MOCA
 “neuropsychology”
Yes/no
 Has detailed neuropsychological testing 
been considered or conducted if there 
has been under performance/low scores 
on screening tools (i.e. the ACe-3)?
0 or 1
Table 1. (Continued)
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the minimum standard (D(403) = 0.128, p’<’.001), and the gold 
standard (D(403) = 0.063, p <.001), therefore non-parametric 
tests were used.
Analysis of variation in compliance across groups
Independent-samples median tests (k-groups) were performed 
to examine compliance with the minimum standard at each of 
the sites. If the omnibus test showed a statistically significant 
difference, then pairwise comparison between sites, adjusted 
for multiple comparisons (28 comparisons), were conducted 
using a Bonferroni correction. Multiple regression analysis was 
used to investigate associations between the compliance rates 
and age, gender, years since diagnosis and diagnosis group (AD 




A total of 402 records from the eight sites met the inclusion 
criteria and were included in the audit. Appendix 3 highlights 
the number of records collected from each of the sites.
Descriptive demographics
Demographic variables collected included gender, age, num-
bers of years since diagnosis, time from referral to service to 
diagnosis and dementia subtype as indicated by clinician-as-
signed ICD codes (see Tables 2 and 3).
Percentage compliance rates analysed by site and statement, 
including compliance for site for minimum standard (11 state-
ments), the additional 20 statements required for Gold standard, 
and the complete Gold standard set (31 statements) were cal-
culated (Table 4 see below) .
Diagnosis Subtypes: 18 different ICD-10 codes were identified 
by the SQL query and 14 different dementia subtypes (See 
appendix 1 for the breakdown). For the purpose of the analysis, 
diagnoses were group into one of four broad categories: 
Alzheimer’s disease (including mixed dementia), Vascular 
dementia, Dementia in Pick’s disease and ‘Other’
Variation in percentage compliance with minimum and 
gold standard between sites
Minimum standard: Independent-Samples Median tests 
showed that there were statistically significant differences 
(p<.05) between three pairs of sites: site E had lower Minimum 
Standard compliance than Site D (padj=.032, effect size r = 0.31, 
small) and Site G (padj=.001, r = 0.55, large), and Site C’s compli-
ance was lower than Site G (padj=.016,r = 0.34, small) .
Gold standard: There were statistically significant differences 
between some sites; site E has lower median compliance per-
centage than all other sites (padj from <.001 to.036, effect sizes 
r = 0.58, large to r = 0.28, small) and there was also a statistically 
significant difference between the percentages for sites H and 
C, with C having the higher compliance (padj=.002, r = 0.38, 
medium). See Figure 1 for variation in percentage compliance 
with minimum and gold standard at sites.
Variation in percentage compliance for minimum and 
gold standard between dementia types
Minimum Standard: An Independent-Samples Median test was 
conducted which showed there were statistically significant 
differences in the percentage compliance between dementia 
types (test statistic = 9.09, df = 3, p=.028). Pairwise comparisons 
showed that there was a difference between those with 
Alzheimer’s disease and Dementia in Pick’s disease (padj=.043,ef-
fect size, r = 0.17, very small), with Pick’s disease being associ-
ated with higher compliance. There were no significant 
differences between the other dementia diagnoses. See Figure 
2 for percentage compliance for minimum and gold standard 
across dementia types.
Gold Standard: There were no statistically significant differ-
ences between diagnostic groups and percentage compliance 
with the gold standard.
Associations between compliance rates and patient 
factors
As the Minimum standard compliance rate had been to vary 
between sites, a multi-level linear model, with site as the ran-
dom, level 2 variable, was constructed to investigate associa-
tions between the compliance rates for the Minimum standard 
statements and age, gender, years since diagnosis and diagnosis 
Table 2. Descriptive demographics from the 402 audited records (across all 
sites).
Variables (Across all sites) Frequency (%)
Median (inter-quartile 
range)
gender 193 Female 
(48.0%); 209 
Male (52.0%)
Age 61 years (58-64)
time since diagnosis: 2 years (2-4)
Diagnosis type:
Alzheimer’s disease 272 (67.7%)
Vascular dementia 83 (20.6%)
Dementia in Pick’s disease 33 (8.2%)
Other 14 (3.5%)
Table 3. number of days from referral to diagnosis (all sites).
Diagnosis group Median (inter-quartile range)
No. of days to 
diagnosis
Alzheimer’s disease 155 days (58 − 389.5)
Vascular dementia 117 days (51 − 384)
Dementia in Pick’s disease 154 days (78 − 344)
Other 117 (40 − 397)
Table 4. Median and interquartile range quartile scores for compliance on the 
Minimum and gold Standard, for the eight anonymised sites removed and 
replaced as below.
Site identifier Median (inter-quartile range)
Minimum 
Standard
A 36.36 (27.27 − 45.45)
  B 36.36 (29.55 − 45.45)
  C 36.36 (27.27 − 40.91)
  D 36.36 (27.27 − 45.45)
  e 27.27 (18.18 − 36.36)
  F 36.36 (27.27 − 45.45)
  g 45.45 (36.36 − 54.55)
  H 31.82 (27.27 − 40.91)
gold Standard A 44.35 (38.71 − 50.00)
  B 41.94 (35.48 − 49.19)
  C 48.39 (37.10 − 54.84)
  D 45.16 (38.71 − 53.23)
  e 32.26 (25.81 − 35.48)
  F 40.32 (33.87 − 51.61)
  g 47.58 (41.94 − 51.61)
  H 38.71 (32.26 − 45.16)
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group, clustered by site. Assumptions of multicollinearity, 
homoscedasticity and normality of residuals were tested and 
met. Only diagnosis group was a significant predictor 
(F(3,391.24)=4.126, p=.007). This confirms the results from the 
Independent-Samples Median test reported above.
This was repeated for the full Gold standard (31 items) which 
showed no associations with any of the predictor variables.
In summary, there were statistically significant compliance 
rates between the sites and there were also differences in the 
Minimum standard compliance rate between patients with dif-
ferent diagnoses, after age, gender and time since diagnosis 
had been accounted for. Gold standard compliance rates were 
not associated with any of these personal variables.
Percentage compliance with individual indicators
Percentage compliance rates analysed by site and statement, 
including compliance for site for minimum standard (11 state-
ments), the additional 20 statements required for Gold standard, 
and the complete Gold standard set (31 statements) were cal-
culated (Table 4). This clearly shows that the additional 20 
statements in the Gold standard had consistently higher com-
pliance rates for every site than the minimum set, hence the 
higher compliance for Gold compared to minimum overall.
The 31 indicators included in the Gold standard were ranked 
and are shown in Table 5.
The results demonstrate wide variability in percentage com-
pliance across the indicators regardless of diagnosis type or site 
with the top indicators yielding scores of over 90%. Low scoring 
Table 5. Percentage compliance rates broken down by site and statement on 








statements for gOlD 
standard (%)
Percentage 
compliance per site 
for all statements 
n/31 gOlD 
standard (%)
A 38 47 44
B 39 43 41
C 35 52 46
D 37 48 44
e 28 33 31
F 37 45 42
g 45 48 47
H 33 40 37
Figure 1. Variation in percentage compliance with minimum (left) and gold (right) standard at sites.
Figure 2. Variation in percentage compliance for minimum (left) and gold (right) standard across dementia types.
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indicators included assessment for neurological signs, preas-
sessment counselling and ascertaining a history of learning 
disability. In some circumstances although there is clear agree-
ment about the value of specific indicators e.g. structural imag-
ing across all sites reaching 90% compliance, execution to an 
acceptable ‘expert consensus’ standard was less common.
Discussion
Quality of diagnosis and equity in access to specialists with 
expertise remains an issue for those with Young Onset Dementia 
(O’Malley, Parkes, Campbell, et al., 2020; Rabanal, Chatwin, 
Walker, O’Sullivan, & Williamson, 2018; Vernooij-Dassen, 2006). 
Misdiagnosis due to other causes, particularly psychiatric 
disorders are common because of complexity and heterogene-
ity in presenting symptoms (Vieira et al., 2013). Mitigation of 
these issues could be achieved by increased knowledge and 
rigorous and systematic approach to diagnosis (Millenaar et al., 
2016; O’Malley et al., 2019; Sansoni et al., 2016). No research 
about current UK practice is available.
In order to understand current diagnostic practice for 
younger people with dementia in the UK memory services, 
compliance with expert-defined quality indicators (O’Malley, 
Parkes, Stamou, et al.) in an anonymised dataset of 402 patients 
with young onset dementia using the UK Clinical Research 
Interactive System (CRIS) across eight NHS trusts was investi-
gated. This study is currently the largest to utilise the digital 
platform UK-CRIS and is a component of the largest UK study 
of young onset dementia. The study was carried out in mental 
health trusts as this is where the majority of young people with 
dementia are diagnosed (Stamou et al., 2020).
 Percentage compliance rates were analysed by site and 
statement for a Minimum standard (11 statements, ranges 
28–45%), the additional 20 statements required for Gold stan-
dard, ranges 33–52%), and the complete Gold standard set (31 
statements, ranges 31–47%). This analysis shows that the addi-
tional 20 statements in the Gold standard had consistently 
higher compliance rates than the minimum set at every site, 
resulting in higher compliance for the Gold standard compared 
to Minimum standard overall.
In patients with a final diagnosis of Frontotemporal Dementia 
(ICD coding - Dementia in Pick’s Disease), percentage compli-
ance with the minimum standard was higher than for 
Alzheimer’s disease (and no higher than for other diagnostic 
groups). Examination of the components of the minimum stan-
dard suggest that this may not be surprising since it contains 
two indicators that are arguably more specific to Frontotemporal 
Dementia (FTD) than other diagnoses; international criteria for 
FTD and a change in behaviour. There was no statistical differ-
ence in time to diagnosis from referral to site with diagnosis 
subtype.
Percentage compliance with the Gold Standard did not vary 
across diagnostic groups suggesting that this standard may be 
more useful as a clinical tool. Perhaps, not surprisingly, for 
assessments conducted in mental health trusts, items con-
cerned with assessment of mental state, mood and risk were 
convincingly assessed within this standard, while assessment 
and/or recording of indicators requiring neurological examina-
tion for key signs was less common. Furthermore, discrepancies 
were apparent. For example, although conducting structural 
neuroimaging scored highly for all sites, performing this to a 
recognised standard such as an MRI ‘dementia protocol’ 
was rare.
The variable compliance rates across sites were evaluated 
further in a follow-up knowledge exchange session with rep-
resentatives of the clinical teams whose notes informed the 
audit. The goal was to identify ‘on the ground’ experience and 
to understand further the barriers and facilitators to improving 
practice. Clinicians advised that use of a standard proforma in 
the clinics to guide enquiry was rare. One site indicated that a 
letter template sent to GPs acted as an aide memoire for record-
ing key elements after the assessment. Clinical teams also iden-
tified that in cases where nurses were performing assessments, 
the proformas were relatively rudimentary and did not distin-
guish between YOD and LOD with regard to specific items of 
enquiry at a level of detail to reach the gold standard. With 
regard to some indicators, for example pre-assessment 
Table 6. Percentage compliance for individual indicators of the gold Standard 
across the whole dataset (402 records) ranked in order.
Statement
Percentage compliance across 
sites, and all dementia types 
(%)
to understand the symptom type and the 
mode of onset
94
to conduct baseline structural 
neuroimaging
91
to ask an informant (e.g. wife/husband) for 
a collateral history
86
to evaluate risks, for example driving or in 
the workplace
85
to exclude symptoms of mood disorder 84
if there have been any changes in activities 
of daily living
74
to consider previous medical conditions 72
to ask about sleep 71
to exclude psychotic symptoms 67
to include a mental state examination 61
to conduct the ACe-iii 60
to take an alcohol history 52
Ask about past psychiatric symptoms 51
MRi should be the initial imaging 
investigation
47
to have a full medical history (including 
cardiovascular history)
45
to use ACe-iii to understand the cognitive 
profile
35
establishing rapport to enable open 
reporting of symptoms
30
Detailed neuropsychology testing should 
be considered if there is under 
performance on screening measures
30
to enquire about changes in physical health 29
to conduct a physical examination 28
to ask about changes in behaviour 24
to take a drug history 22
to ask if a first degree relative has had 
young onset dementia
19
to obtain a three-generation history of 
young onset dementia from the patient
11
to assess neurological symptoms, including 
eye movements, 
Cerebellar signs, 
tongue or limb fasciculation, Frontal 
signs, extrapyramidal features Motor 
Skills
10
to conduct MRi dementia protocol 
incorporating t1, t2 and Flair images
9
to assess Parkinsonism 7
to ask for information about loss of 
sympathy/empathy towards others, 
disinhibited behaviour, change in food 
preferences and changes in personality
6
to assess Praxis 5
the assessment should start with 
counselling to ascertain what patient 
and supporters require
3
establish if there is a known history of 
learning disability
3
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counselling, teams reported that often a scripted proforma was 
used to meet MSNAP (Memory Service National Accreditation 
Programme) standards rather than individually tailored coun-
selling which takes account of age-specific needs.
In summary, initial analysis of anonymised data for patients 
with YOD using expert-defined quality indicators has provided 
a baseline about variation in the information that is currently 
recorded in EHR.
A major strength of our dataset is the comprehensive inclu-
sion of the population of interest, across eight different NHS 
trusts. The analysed sample therefore encompasses differing 
care pathways and practice allowing highly generalisable results.
Furthermore, deriving structured information directly from 
the text fields held in mental health records allowed accurate 
representation of contemporaneous records. Keywords for our 
search query were aimed at identifying clinician-assigned con-
structs, rather than descriptions of experiences.
Limitations for the study included the level of detail within 
the notes which differed greatly between the sites. Whilst some 
sites followed usual clinical clerking, which included key queries 
to investigate and note during the initial and subsequent 
assessments, other sites summarised assessments concisely in 
a freehand manner. It should also be noted that the some of the 
consensus indicators required a level of subjectivity in assess-
ment. For example, the indicator related to rapport was scored 
according to whether the term ‘rapport’ was used, or if the cli-
nician’s language suggested that questions were directed more 
towards the person undergoing the assessment (rather than a 
family supporter) and if they described the personality of the 
person, suggesting that they attempted to get to know the 
patient as well as possible. Finally, the study includes records 
from Mental Health Trusts, so patients with YOD assessed in 
neurology centres/services, would not have been included and 
this limits generalisability of the findings. Ideally, capturing 
records from those assessed in neurology and specialist services 
would provide greater understanding of differences in patient 
initial complaints and profiles between mental health and neu-
rology services.
In other fields of medicine, introduction of interventions 
such as aide memoire in addition to clinical education has been 
valuable in improving standards of good practice (Parwaiz, 
Perera, Creamer, Macdonald, & Hunter, 2017). The results 
obtained here, suggest that a template proforma, which con-
tains the key indicators for comprehensive assessment of 
dementia in young adults according to a quality standard could 
help support less experienced clinicians to improve record 
keeping and reduce gaps in examination and enquiry.
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Appendix 1. Dementia diagnoses included in the case note audit
iCD-10 Code Diagnosis grouping Diagnosis
F00 Dementia in Alzheimer’s disease Alzheimer’s disease
f000 Dementia in Alzheimer’s disease with early onset Alzheimer’s disease
F000 Dementia in Alzheimer’s disease with early onset Alzheimer’s disease
F001 Dementia in Alzheimer’s disease with late onset Alzheimer’s disease
F002 Dementia in Alzheimer’s disease, atypical or mixed type Alzheimer’s disease
F009 Dementia in Alzheimer’s disease, unspecified Alzheimer’s disease
F01 Vascular dementia Vascular dementia
F010 Vascular dementia of acute onset Vascular dementia
F011 Multi-infarct dementia Vascular dementia
F013 Mixed cortical and subcortical vascular dementia Vascular dementia
F018 Other vascular dementia Vascular dementia
F019 Vascular dementia, unspecified Vascular dementia
f020 Dementia in Pick’s disease Dementia in Pick’s disease
F020 Dementia in Pick’s disease Dementia in Pick’s disease
F022 Dementia in Pick’s disease Dementia in Pick’s disease
F028 Dementia in other specified diseases classified elsewhere Other
g318 Other specified degenerative diseases of the nervous system Other
F02 Dementia in other specified diseases classified elsewhere Other
Appendix 2. Statements that were not included in the audit and reasons for exclusion and combining.
Standard that 
Delphi-PRO statement 
belongs to Statement in Delphi consensus but not audit Reasons
Minimum Standard A thorough neuroimaging investigation should be included Was combined with the “baseline structural neuroimaging” 
statement and added to gold standard








Minimum Standard Support is required from diagnosis to end of life care Unable to extract this from the case note records
Minimum Standard Diagnosis of YOD is a clinical judgement and has a profound impact on 
the future, so it important to convey this to patient and their family 
and remain open to the need to review and potentially modify 
opinion
Unable to extract this from the case note records
gold Standard ensuring the patient has capacity Could not extract this from the case note records
gold Standard Multiple professionals are required over time to allow flexible 
assessment with support to end of life
Could not extract this from the case note records
Appendix 3. Frequency and percentage of records from each of the participating sites in the audit.
Frequency of records 
(percentage)
Site identifier A 58 (14.4%)
B 52 (12.9%)
C 53 (13.2%)
D 50 (12.4%)
e 53 (13.2%)
F 50 (12.2%)
g 50 (12.4%)
H 36 (9%)
total 402 (100%)
